Pure Global AI
NCT06038149Not yet recruiting

Improving Pulmonary Hypertension Screening by Echocardiography

Royal United Hospitals Bath NHS Foundation TrustClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
Transthoracic echocardiogram
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Royal United Hospitals Bath NHS Foundation Trust
Location
Bath,Glasgow,Sheffield,Cambridge,London, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Oct 19, 2023
End date
Feb 01, 2025
Enrollment
200 participants
Primary outcome

Analysis of the IMPULSE algorithm in the assessment of pulmonary hypertension,Analysis of the IMPULSE algorithm in comparison to existing guidlines

Summary

This study aims to assess the application of the novel IMPULSE algorithm for the detection of
 pulmonary hypertension (PH) in those with a low or intermediate probability of PH according
 to the British Society of Echocardiography (ESC) and European Society of Cardiology (ESC)
 guidelines.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06038149
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06038149 through Pure Global AI's free database. This phase not specified trial is sponsored by Royal United Hospitals Bath NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.